Quidel (NASDAQ: QDEL) — Perfil da empresa, notícias e dados financeiros
Quidel is a diagnostic healthcare manufacturer specializing in innovative testing solutions for critical diseases and conditions.
Quidel
Quidel (NASDAQ:QDEL) is a renowned diagnostic healthcare manufacturer focused on developing and producing innovative testing solutions aimed at enhancing patient outcomes and providing clinical value across various medical settings. Their portfolio covers a broad range of products intended for the diagnosis and monitoring of critical diseases and conditions, ranging from infectious diseases to cardiology and bone health. Quidel is known for its rapid diagnostic tests, including point-of-care tests that deliver quick and accurate results, facilitating timely treatment decisions. With a commitment to research and development, Quidel aims to advance medical diagnostics through continuous innovation, striving to meet the evolving healthcare needs of communities worldwide. Their mission revolves around empowering healthcare professionals with reliable, accessible, and easy-to-use diagnostic tools that can significantly impact patient care.
Resumo
Operações
Produtos e/ou serviços de Quidel
- Immunoassay and molecular testing: This includes rapid tests, like those used for COVID-19 or strep throat, alongside more complex tests for various diseases and conditions.
- Clinical chemistry: Analyzes various components in blood or other bodily fluids to assess organ function and identify potential health issues.
- Immunohematology: Focuses on blood typing and compatibility testing, crucial for blood transfusions and organ transplants.
- Blood bank solutions and transfusion pre-screening: Offers equipment and tests to ensure safe and effective blood transfusions.
- Laboratory automation and data management: Provides tools and systems to streamline lab workflows and improve data analysis.
- Service and support: Offers technical assistance, training, and other support resources to healthcare professionals utilizing their products.
equipe executiva do Quidel
- Brian J. BlaserPresident, CEO & Director
- Philip D. McLellanChief Operations Officer
- Jonathan P. SiegristExecutive VP of Research & Development and CTO
- Micah YoungChief Financial Officer & Principal Financial Officer
- Juliet C. CunninghamVice President of Investor Relations
- Nathaniel B. SisitskyChief Legal Officer & Corporate Secretary
- Lisa S. HayesVice President of Global Marketing & Corporate Communications
- Bryan M. HansonExecutive VP of Global Portfolio Management and Marketing
- Erich WolffExecutive Vice President of Strategy & Corporate Development
- Ronald Lee BowmanChief Human Resources Officer
Últimas notícias sobre a Quidel
Principais indicadores financeiros
Resultados divulgados pela Quidel , em USD.
- Cap. de mercado
- 931,9 mi
- Receita (TTM)
- 2,7 bi
- P/L
- —
- LPA (diluído, TTM)
- -15.4
- Dividend yield
- —
- Margem de lucro
- -39.2%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 2,7 bi | -919,2 mi | -1,1 bi | |
| 2,8 bi | -2 bi | -2,1 bi | |
| 3 bi | 139,1 mi | -10,1 mi | |
| 3,3 bi | 843,7 mi | 548,7 mi |